Management of Methanol (Methyl Alcohol) Poisoning
Immediately administer fomepizole as the first-line antidote to block alcohol dehydrogenase and prevent formation of toxic metabolites, combined with hemodialysis for severe cases, sodium bicarbonate for acidosis correction, and folinic acid to enhance formate metabolism. 1
Initial Stabilization and Antidote Administration
Fomepizole (Preferred Antidote)
- Fomepizole is the preferred antidote over ethanol due to simpler dosing, easier maintenance of therapeutic concentrations, fewer adverse effects, and no need for complex monitoring 2, 1
- Administer fomepizole urgently in severe poisoning to block methanol metabolism by alcohol dehydrogenase 3
- Continue fomepizole during hemodialysis at 1 mg/kg/hour continuous infusion to compensate for dialytic removal 4
- Fomepizole dosing requires adjustment during extracorporeal treatment 2
Ethanol (Alternative Antidote)
- Use ethanol only when fomepizole is unavailable 1
- Ethanol has significant disadvantages including complex dosing, difficulty maintaining therapeutic concentrations, need for comprehensive monitoring, and more adverse effects 1
- Ethanol therapy carries risks of CNS depression and dysphoria, requiring high-dependency unit admission 2
Indications for Hemodialysis
Strong Recommendations for Hemodialysis
The following criteria mandate hemodialysis 3:
- Severe clinical manifestations: coma, seizures, or new vision deficits attributed to methanol 3
- Metabolic acidosis: blood pH ≤ 7.15 3
- Persistent metabolic acidosis despite adequate supportive measures and antidotes 3
- Elevated anion gap: serum anion gap > 24 mmol/L 3
- Impaired kidney function in the context of methanol poisoning 3
Methanol Concentration Thresholds for Hemodialysis
The indication varies based on antidote availability 3:
- With fomepizole: methanol concentration > 700 mg/L (21.8 mmol/L) 3
- With ethanol: methanol concentration > 600 mg/L (18.7 mmol/L) 3
- Without alcohol dehydrogenase blocker: methanol concentration > 500 mg/L (15.6 mmol/L) 3
When Hemodialysis May Be Avoided
- In selected patients treated with fomepizole before onset of significant acidosis, neurological impairment, ocular impairment, or severe acidosis, hemodialysis may not be required 4
- This decision requires careful clinical judgment and continuous monitoring 4
Hemodialysis Modality and Duration
Preferred Modality
- Intermittent hemodialysis is the modality of choice for methanol poisoning 3
- Continuous renal replacement therapy is an acceptable alternative when intermittent hemodialysis is unavailable 3
Cessation Criteria
- Stop hemodialysis when methanol concentration is < 200 mg/L (6.2 mmol/L) AND clinical improvement is observed 3
- Continue alcohol dehydrogenase inhibitors and folinic acid during extracorporeal treatment 3
Adjunctive Therapies
Metabolic Acidosis Correction
- Administer intravenous sodium bicarbonate to correct metabolic acidosis caused by formic acid accumulation 1, 5
- Sodium bicarbonate helps normalize blood pH 5
Folinic Acid Administration
- Administer intravenous folinic acid to enhance formic acid metabolism and conversion to carbon dioxide and water 1
- Folinic acid should be given in patients with ophthalmologic abnormalities or significant acidosis 1
Clinical Monitoring Priorities
Key Laboratory Parameters
- Monitor blood pH, anion gap, and osmolal gap (when methanol concentration unavailable) 3
- The osmolal/osmolar gap may be informative when methanol concentration is not immediately available 3
Visual Function Assessment
- Assess for visual disturbances ranging from blurred vision and altered visual fields to complete blindness 1
- Visual impairments result from formic acid interaction with the optic nerve 5
Timing Considerations
- A latent period of approximately 12-24 hours occurs after ingestion before toxic symptoms develop, depending on methanol dose and ethanol co-ingestion 1, 5
- Initiate antidotes and hemodialysis urgently in severe poisoning without waiting for laboratory confirmation 3
Critical Pitfalls to Avoid
- Do not delay antidote administration waiting for methanol levels; treat based on clinical suspicion and surrogate markers 3
- Avoid systemic anticoagulation during hemodialysis as it may increase risk of intracerebral hemorrhage 3
- Do not rely solely on reported methanol dose for treatment decisions 2
- Recognize that co-ingestion of ethanol delays metabolism and extends the latent period before toxicity develops 5